{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:24:39Z","timestamp":1787181879145,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022536","name":"Prince of Songkla University Faculty of Science","doi-asserted-by":"publisher","award":["1-2567-02-030"],"award-info":[{"award-number":["1-2567-02-030"]}],"id":[{"id":"10.13039\/501100022536","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017413","name":"Innovation Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004508","name":"Prince of Songkla University","doi-asserted-by":"publisher","award":["VET6701308S"],"award-info":[{"award-number":["VET6701308S"]}],"id":[{"id":"10.13039\/501100004508","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004508","name":"Prince of Songkla University","doi-asserted-by":"publisher","award":["VET6804195S"],"award-info":[{"award-number":["VET6804195S"]}],"id":[{"id":"10.13039\/501100004508","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.biopha.2026.119820","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:22:34Z","timestamp":1785428554000},"page":"119820","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The chalcone derivative DN-053 attenuates renal fibrosis and inhibits p38 MAPK and STAT3 signaling in renal fibroblasts"],"prefix":"10.1016","volume":"202","author":[{"given":"Sudaphon","family":"Srichan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1376-3253","authenticated-orcid":false,"given":"Pissared","family":"Khuituan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4631-3745","authenticated-orcid":false,"given":"Krittee","family":"Dejyong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natapol","family":"Duangtum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julaluk","family":"Jiangsakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chayada","family":"Yoksiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nattanun","family":"Hautavanija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukrit","family":"Sangjun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fittree","family":"Hayeeawaema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warinthorn","family":"Chavasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchada","family":"Kaewin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chatchai","family":"Muanprasat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3320-5403","authenticated-orcid":false,"given":"Paradorn","family":"Muangnil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119820_bib1","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0140-6736(25)01853-7","article-title":"Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023","volume":"406","author":"GBD 2023 Chronic Kidney Disease Collaborators","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2026.119820_bib2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","article-title":"Chronic kidney disease and the global public health agenda: an international consensus","volume":"20","author":"Francis","year":"2024","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.biopha.2026.119820_bib3","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119820_bib4","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119820_bib5","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-physiol-022516-034227","article-title":"Mechanisms of renal fibrosis","volume":"80","author":"Humphreys","year":"2018","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.biopha.2026.119820_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tem.2023.09.001","article-title":"Mechanisms of kidney fibrosis and routes towards therapy","volume":"35","author":"Yamashita","year":"2024","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2026.119820_bib7","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1053\/j.ajkd.2020.08.015","article-title":"Histopathologic correlates of kidney function: insights from nephrectomy specimens","volume":"77","author":"Li","year":"2021","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.biopha.2026.119820_bib8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.biopha.2026.119820_bib9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3892\/mmr.2024.13267","article-title":"TGF-\u03b2\/Smad signaling in chronic kidney disease: Exploring post-translational regulatory perspectives","volume":"30","author":"Li","year":"2024","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2026.119820_bib10","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1073\/pnas.90.5.1814","article-title":"Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy","volume":"90","author":"Yamamoto","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2026.119820_bib11","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2337\/diab.46.5.854","article-title":"S.M. Wasserman, Increased renal production of transforming growth factor-beta1 in patients with type II diabetes","volume":"46","author":"Sharma","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2026.119820_bib12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrneph.2017.85","article-title":"Redefining lupus nephritis: clinical implications of pathophysiologic subtypes","volume":"13","author":"Yu","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.biopha.2026.119820_bib13","doi-asserted-by":"crossref","first-page":"F861","DOI":"10.1152\/ajprenal.00362.2001","article-title":"J.J. Morissey, Obstructive nephropathy and renal fibrosis","volume":"283","author":"Klahr","year":"2002","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.biopha.2026.119820_bib14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/346371a0","article-title":"Suppression of experimental glomerulonephritis by antiserum against transforming growth factor \u03b21","volume":"346","author":"Border","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119820_bib15","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/bab.1667","article-title":"Preparation and evaluation of anti-renal fibrosis activity of novel truncated TGF-\u03b2 receptor type II","volume":"65","author":"Liu","year":"2018","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.biopha.2026.119820_bib16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ki.1996.297","article-title":"Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis","volume":"50","author":"Akagi","year":"1996","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2026.119820_bib17","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1073\/pnas.92.7.2572","article-title":"Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions","volume":"92","author":"Sanderson","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2026.119820_bib18","first-page":"991","article-title":"Thorgeirsson, Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease","volume":"74","author":"Kopp","year":"1996","journal-title":"Lab. Invest."},{"key":"10.1016\/j.biopha.2026.119820_bib19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/ki.2014.287","article-title":"Origin of myofibroblasts and cellular events triggering fibrosis","volume":"87","author":"Mack","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2026.119820_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","article-title":"Kidney fibrosis: from mechanisms to therapeutic medicines","volume":"8","author":"Huang","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2026.119820_bib21","doi-asserted-by":"crossref","first-page":"F596","DOI":"10.1152\/ajprenal.00365.2015","article-title":"TGF-\u03b2 signaling in the kidney: profibrotic and protective effects","volume":"310","author":"Sureshbabu","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.biopha.2026.119820_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fcell.2020.00123","article-title":"Diverse role of TGF-\u03b2 in kidney disease","volume":"8","author":"Gu","year":"2020","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.biopha.2026.119820_bib23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","article-title":"TGF-\u03b2 signaling in health, disease and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2026.119820_bib24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ymthe.2023.12.009","article-title":"Therapeutic potential for renal fibrosis by targeting Smad3-dependent noncoding RNAs","volume":"32","author":"Gu","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2026.119820_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111386","article-title":"Small molecules against the origin and activation of myofibroblast for renal interstitial fibrosis therapy","volume":"139","author":"Feng","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2026.119820_bib26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semcdb.2019.11.013","article-title":"Non-canonical (non-SMAD2\/3) TGF-\u03b2 signaling in fibrosis: mechanisms and targets","volume":"101","author":"Finnson","year":"2020","journal-title":"Semin. Cell. Dev. Biol."},{"key":"10.1016\/j.biopha.2026.119820_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cyto.2016.08.019","article-title":"The cellular and signalling alterations conducted by TGF-\u03b2 contributing to renal fibrosis","volume":"88","author":"Vega","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2026.119820_bib28","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3390\/biom11060894","article-title":"Chalcone derivatives: role in anticancer therapy","volume":"11","author":"Ouyang","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2026.119820_bib29","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10311-019-00959-w","article-title":"Chalcone synthesis, properties and medicinal applications: a review","volume":"18","author":"Rammohan","year":"2020","journal-title":"Environ. Chem. Lett."},{"key":"10.1016\/j.biopha.2026.119820_bib30","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2147\/DDDT.S243420","article-title":"Isoliquiritigenin attenuates UUO-induced renal inflammation and fibrosis by inhibiting Mincle\/Syk\/NF-\u03baB signaling pathway","volume":"14","author":"Liao","year":"2020","journal-title":"Drug. Des. Dev. Ther."},{"key":"10.1016\/j.biopha.2026.119820_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13476","article-title":"trans-Chalcone inhibits high-fat diet-induced disturbances in FXR\/SREBP-1c\/FAS and FXR\/Smad-3 pathways in the kidney of rats","volume":"44","author":"Alipour","year":"2020","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.biopha.2026.119820_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115098","article-title":"Discovery of a chalcone derivative as an anti-fibrotic agent targeting transforming growth factor-\u03b21 signaling: potential therapy of renal fibrosis","volume":"165","author":"Poolsri","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2026.119820_bib33","first-page":"52559","article-title":"A murine model of irreversible and reversible unilateral ureteric obstruction","author":"Hesketh","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.biopha.2026.119820_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115166","article-title":"Novel insights into STAT3 in renal diseases","volume":"165","author":"Yu","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2026.119820_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110473","article-title":"Deletion of STAT3 from Foxd1 cell population protects mice from kidney fibrosis by inhibiting pericytes trans-differentiation and migration","volume":"38","author":"Ajay","year":"2022","journal-title":"Cell. Rep."},{"key":"10.1016\/j.biopha.2026.119820_bib36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/ki.2010.154","article-title":"A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy","volume":"78","author":"Pang","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2026.119820_bib37","doi-asserted-by":"crossref","first-page":"F495","DOI":"10.1152\/ajprenal.2001.280.3.F495","article-title":"Stimulation of pro-alpha(1)(I) collagen by TGF-beta(1) in mesangial cells: role of the p38 MAPK pathway","volume":"280","author":"Chin","year":"2001","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.biopha.2026.119820_bib38","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/01.ASN.0000109669.23650.56","article-title":"The role of p38alpha mitogen-activated protein kinase activation in renal fibrosis","volume":"15","author":"Stambe","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2026.119820_bib39","article-title":"p38 MAPK activity is associated with the histological degree of interstitial fibrosis in IgA nephropathy patients","volume":"14","author":"Lee","year":"2019","journal-title":"PLOS One"},{"key":"10.1016\/j.biopha.2026.119820_bib40","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14627","article-title":"STX-0119, a novel STAT3 dimerization inhibitor, prevents fibrotic gene expression in a mouse model of kidney fibrosis by regulating Cxcr4 and Ccr1 expression","volume":"8","author":"Makitani","year":"2020","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.biopha.2026.119820_bib41","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/s41419-019-2085-0","article-title":"Inhibition of STAT3 in tubular epithelial cells prevents kidney fibrosis and nephropathy in STZ-induced diabetic mice","volume":"10","author":"Zheng","year":"2019","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.biopha.2026.119820_bib42","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nri2095","article-title":"TGFbeta signalling in control of T-cell-mediated self-reactivity","volume":"7","author":"Rubtsov","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2026.119820_bib43","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3810","article-title":"Targeting the TGF\u03b2 signalling pathway in disease","volume":"11","author":"Akhurst","year":"2012","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.biopha.2026.119820_bib44","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev-immunol-101921-045939","article-title":"TGF-\u03b2 regulation of T cells","volume":"41","author":"Chen","year":"2023","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.biopha.2026.119820_bib45","doi-asserted-by":"crossref","first-page":"842","DOI":"10.4049\/jimmunol.0904100","article-title":"Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development","volume":"185","author":"Takimoto","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2026.119820_bib46","doi-asserted-by":"crossref","first-page":"a022236","DOI":"10.1101\/cshperspect.a022236","article-title":"Regulation of the immune response by TGF-\u03b2: from conception to autoimmunity and infection","volume":"9","author":"Sanjabi","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.biopha.2026.119820_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1066375","article-title":"Dysregulation of the immune response in TGF-\u03b2 signalopathies","volume":"13","author":"Rodari","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119820_bib48","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.4049\/jimmunol.0903418","article-title":"Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells","volume":"184","author":"Lu","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2026.119820_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70152","article-title":"STAT3 signaling pathway in health and disease","volume":"6","author":"Samad","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.biopha.2026.119820_bib50","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.4049\/jimmunol.1001455","article-title":"Stat3 phosphorylation mediates resistance of primary human T cells to regulatory T cell suppression","volume":"186","author":"Goodman","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2026.119820_bib51","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/s41467-017-01236-6","article-title":"Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis","volume":"8","author":"Chakraborty","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119820_bib52","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/MMBR.00031-10","article-title":"Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases","volume":"75","author":"Cargnello","year":"2011","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.biopha.2026.119820_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.781282","article-title":"Dermal fibroblast migration and proliferation upon wounding or lipopolysaccharide exposure is mediated by stathmin","volume":"12","author":"Cen","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119820_bib54","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1096\/fj.06-7859rev","article-title":"Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival","volume":"22","author":"Junttila","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2026.119820_bib55","doi-asserted-by":"crossref","first-page":"13284","DOI":"10.1021\/acs.jafc.3c01880","article-title":"Nephroprotective effects of cardamonin on renal ischemia reperfusion injury\/UUO-induced renal fibrosis","volume":"71","author":"Zhang","year":"2023","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2026.119820_bib56","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/jcmm.13973","article-title":"Chalcone flavokawain A attenuates TGF-\u03b21-induced fibrotic pathology via inhibition of ROS\/Smad3 signaling pathways and induction of Nrf2\/ARE-mediated antioxidant genes in vascular smooth muscle cells","volume":"23","author":"Hseu","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2026.119820_bib57","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.2147\/DDDT.S282206","article-title":"Xanthohumol inhibits TGF-\u03b21-induced cardiac fibroblasts activation via mediating PTEN\/Akt\/mTOR signaling pathway","volume":"14","author":"Jiang","year":"2020","journal-title":"Drug. Des. Dev. Ther."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T22:45:25Z","timestamp":1787179525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226008565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":57,"alternative-id":["S0753332226008565"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119820","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The chalcone derivative DN-053 attenuates renal fibrosis and inhibits p38 MAPK and STAT3 signaling in renal fibroblasts","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119820","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119820"}}